Litcius/Paper detail

Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study

Florentia Dimitriou, Kenjiro Namikawa, Irene L. M. Reijers, Elizabeth I. Buchbinder, J. Soon, Anne Zaremba, Paweł Teterycz, Meghan J. Mooradian, Emma Armstrong, Yasuhiro Nakamura, Maria Grazia Vitale, Lena Tran, Xue Bai, Clara Allayous, S. Provent-Roy, Alice Indini, Prachi Bhave, Mohamad Farid, Katharina C. Kähler, Inderjit Mehmi, Victoria Atkinson, Oliver Klein, Connor J. Stonesifer, Farzana Y. Zaman, Andrew Haydon, Richard D. Carvajal, Omid Hamid, Reinhard Dummer, Axel Hauschild, Matteo S. Carlino, Mario Mandalà, Caroline Robert, Célèste Lebbé, Jun Guo, Douglas B. Johnson, Paolo A. Ascierto, Alexander N. Shoushtari, Ryan J. Sullivan, Bożena Cybulska-Stopa, Piotr Rutkowski, Lisa Zimmer, Shahneen Sandhu, Christian U. Blank, Serigne Lo, Alexander M. Menzies, Georgina V. Long

2022Annals of Oncology62 citationsDOIOpen Access PDF

Topics & Concepts

MedicineIpilimumabInternal medicineRetrospective cohort studyCohortOncologyHazard ratioProportional hazards modelConfidence intervalGastroenterologyCancerImmunotherapyCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementMelanoma and MAPK Pathways